Save 10% off on your first order with coupon code: PANDA10

Health & Wellness Blog

4Feb, 2026

Basaglar vs Ozempic: Insulin vs GLP-1 Comparison 2026

February 4, 2026|

Basaglar and Ozempic represent two fundamentally different approaches to diabetes management. Basaglar - a long-acting insulin, containing insulin glargine, steadily keeps blood sugar levels in check over the course of 24 hours, just by topping up the natural insulin that your body's already producing.  Ozempic - a GLP 1 receptor agonist containing semaglutide, however works [...]

2Feb, 2026

Wegovy Constipation: 24% GI Side Effect + Relief Guide – Lasts 47 Days Average

February 2, 2026|

Wegovy constipation affects 24% of users (1 in 4), peaks during the first 16 weeks of treatment, and has a median duration of 47 days caused by approximately 30% slower gut motility from the medication. Wegovy is a GLP-1 receptor agonist that mimics a natural gut hormone. This mechanism supports your weight loss journey but [...]

2Feb, 2026

Does Wegovy Need Refrigeration? 30 Days Room Temp + Forgot Protocol

February 2, 2026|

Yes, unopened Wegovy pens must stay refrigerated (36-46°F), while opened pens are good at room temperature below 86°F for 28 days max. If you've been prescribed Wegovy for your weight loss journey, proper storage is essential to maintain the medication's effectiveness. This FDA-approved weight loss medication contains semaglutide, an active ingredient that's sensitive to temperature [...]

2Feb, 2026

Does Wegovy Cause Hair Loss 2026: 3% Telogen Effluvium + Prevention Guide

February 2, 2026|

Yes, Wegovy hair loss affects approximately 3% of users compared to 1% in the placebo group, according to clinical trials published in the New England Journal of Medicine. However, experts believe this is a temporary side effect caused by telogen effluvium from rapid weight loss, not a direct effect of semaglutide itself. Telogen effluvium occurs [...]

31Jan, 2026

Wegovy Dosing Guide 2026: 0.25mg to 2.4mg Complete Schedule

January 31, 2026|

Wegovy starts at 0.25mg weekly for 4 weeks, gradually increasing to the 2.4mg maintenance dose over approximately 4 months. This gradual dose escalation schedule is specifically designed to minimize gastrointestinal adverse reactions, which affect up to 73% of patients treated with Wegovy in clinical trials (FDA Prescribing Information). Wegovy is a prescription medication administered subcutaneously [...]

31Jan, 2026

Wegovy Side Effects 2026: GI Issues 44%, Hair Loss 3%, Eye Problems 1.6%

January 31, 2026|

Wegovy causes GI side effects in 44% of users, hair loss in 3%, and eye issues in 1.6% of diabetic patients with the highest rates occurring at the 2.4mg maintenance dose.  The most frequently reported reactions are gastrointestinal: nausea affects 44% of adults (compared to 16% on placebo), while diarrhea occurs in 30% of users. [...]

20Feb, 2026

Trulicity Coupon 2026: $25 Savings Card, Copay, Discounts Guide

February 20, 2026|

As of early 2026, the average retail price of Trulicity without insurance is approximately $1,395.75 for four Trulicity pens a standard 30-day supply. The good news: several savings programs exist to help eligible patients dramatically reduce what they pay out [...]

17Feb, 2026

Zepbound Insurance Coverage: Complete Guide to Prior Authorization & Approval

February 17, 2026|

Zepbound insurance coverage stands at approximately 45% for commercial plans requiring BMI ≥30 or ≥27 with comorbidities, while Medicare excludes weight-loss indications entirely. Employer-sponsored plans show 55% approval rates after prior authorization. Roughly 97 million Americans are in plans that [...]

13Feb, 2026

Mounjaro Dosage: Complete 2.5mg→15mg Titration Chart + Missed Dose Protocol

February 13, 2026|

Mounjaro (tirzepatide) is an FDA-approved once-weekly injectable medicine manufactured by Eli Lilly for adults and children aged 10 years and older with type 2 diabetes. The active ingredient tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) [...]

6Feb, 2026

Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery

February 6, 2026|

Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and [...]

5Feb, 2026

Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs – Diabetes vs Obesity Drugs

February 5, 2026|

Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically outperforming Trulicity’s average weight reduction of about 7–10 lbs (3–5% of body weight). Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight [...]

1Sep, 2025

Ozempic vs Insulin

September 1, 2025|

Effective blood glucose management is a critical need for many. Ozempic and insulin are two commonly used diabetes medications. While both address diabetes, they function differently. Ozempic is a prescription medication for adults with type 2 diabetes. Interestingly, it also [...]

4Aug, 2025

Is Compounded Mounjaro Safe? Understanding Tirzepatide Compounding for Informed Choices

August 4, 2025|

Tirzepatide is a prescription drug that has been gaining popularity. Millions are exploring it for weight management and diabetes. But sometimes, the exact medication isn't readily available. This leads to "compounding."  What are Compounded Drugs? Compounded versions of medications are [...]

3Jun, 2025

Does Ozempic Cause Hair Loss?

June 3, 2025|

You've scrolled through social media, seen the news, and maybe even heard friends talking about Ozempic and its remarkable weight loss results. It's become a household name, but with its growing popularity comes a wave of questions, especially regarding potential [...]

Go to Top
X